OBD’s 94% accurate EpiSwitch® Prostate Screening (PSE) blood test is now available to men being screened for prostate cancer.

PSE boosts PSA accuracy from 55% to 94% for confirming the presence or absence of prostate cancer. The highly accurate blood test is simple to order by a physician and is available to men in the US and UK under the immediate access program.

Read more here

Order the PSE Test here

Continue

Featured Stories

Filter by:

Launch of HIPPOCRATES a New €21 million EU and Industry funded Psoriatic Arthritis Research Project led by University College Dublin

NovaUCD |
View Article

Oxford BioDynamics Covid severity test demonstrates 92% accuracy

Medical Device Network |
View Article

The Top 10 Biotech Companies Brewing at Oxford

Labiotech.eu |
View Article

Glasgow University professor joins advisory board of pioneering biotech firm

Insider.co.uk |
View Article

Oxford BioDynamics to Use New Technology as Partner in REFINE-ALS Biomarker Study

ALS News Today |
View Article

Queen’s Awards success for businesses backed by Innovate UK

GOV.UK |
View Article